§ Jane GriffithsTo ask the Secretary of State for Health (1) what the expenditure was on drug treatments for Alzheimer's disease patients in Reading, East for the latest year for which figures are available; [187015]
(2) how many patients are being treated for Alzheimer's disease in Reading, East; and how many of these are receiving drug treatment. [187016]
§ Ms Rosie WintertonInformation on the number of patients treated for Alzheimer's disease by individual primary care trusts (PCTs) is not collected centrally. Data on the number of prescription items dispensed in the community, and the net ingredient cost is collected by the Prescription Pricing Authority. The total number of prescription items dispensed for dementia drugs, and the net ingredient cost of these drugs, in the area covered by Reading PCT in 2003–04 is shown in the table.
1357W
Total number of prescription items and net ingredient cost for "Drugs for Dementia" (BNF 4.11, treatment of Alzheimer's Disease) dispensed in the community for Reading PCT in 2003–04 Number of prescription items Net ingredient cost(£) Reading PCT 96 8,278 England total 392,652 34,217,012 Notes: 1. Prescription cost analysis (PCA) data covers all prescriptions items that are dispensed in the community in England. PCA data does not include items dispensed in hospitals or private prescriptions. 2. Drugs for the treatment of Alzheimer's disease are classified in the British National Formulary section 4.11 (Drugs for Dementia) and include the drugs Donepezil, Rivastigmine, Galantamine and Memantine.
3. Information on the number of patients receiving prescriptions for these drugs is not available, but numbers of prescription items of all prescriptions dispensed in the community in Reading PCT (this is not necessarily the same as where the drugs were prescribed) and the net ingredient cost (NIC) is provided. 4. Prescriptions are written on a prescription form. Each single item written on the form is counted as a prescription item. 5. The NIC is the basic cost of a drug. This cost does not take account of discounts, dispensing costs, fees or prescription charge income. Source: PCA data from the Prescription Pricing Authority.
§ Dr. StoateTo ask the Secretary of State for Health (1)what the total expenditure on drugs available on the NHS for Alzheimer's disease was in Dartford in the latest year for which figures are available; [187025]
(2) how many Alzheimer's disease patients are being treated by primary care trusts in Dartford; [187026]
(3) how much was spent by the NHS on drug treatments for advanced Alzheimer's disease patients in Dartford in the latest year for which figures are available; [187027]
what assessment his Department has made of the availability of drugs for patients with moderately severe to severe Alzheimer's disease in Dartford. [187030]
§ Ms Rosie WintertonInformation on the number of Alzheimer's disease patients being treated by individual primary care trusts (PCTs) is not collected centrally. Data on the number of prescription items dispensed in the community and the net ingredient cost are collected by the Prescription Pricing Authority. The total number of prescription items dispensed for dementia drugs and the net ingredient costs of these drugs, in the area covered by Dartford, Gravesham and Swanley PCT in 2003–04 is shown in the table.
1358W
Total number of prescription items and net ingredient cost for "Drugs for Dementia" (BNF 4.11, treatment of Alzheimer's disease dispensed in the community for Dartford, Gravesham and Swanley PCT in 2003–04 Number of prescription items (Thousand) Net ingredient cost (£000) Dartford, Gravesham and Swanley PCT 1.2 105.5 England total 392.7 34,217.0 Notes: 1. Prescription cost analysis (PCA) data covers all prescription items that are dispensed in the community in England. PCA data does not include items dispensed in hospitals or private prescriptions. 2. Drugs for the treatment of Alzheimer's disease are classified in the British National Formulary section 4.11 (Drugs for Dementia) and include the drugs Donepezil, Rivastigmine, Galantamine and Memantine. 3. Information on the number of patients receiving prescriptions for these drugs is not available, but numbers of prescription items of all prescriptions dispensed in the community in Dartford, Gravesham and Swanley PCT (this is not necessarily the same as where the drugs were prescribed) and the net ingredient cost (NIC) is provided. 4. Prescriptions are written on a prescription form. Each single item written on the form is counted as a prescription item. 5. The NIC is the basic cost of a drug. This cost does not take account of discounts, dispensing costs, fees or prescription charge income. Source: PCA data from the Prescription Pricing Authority. It is not possible to provide a breakdown for expenditure on drug treatments for advanced Alzheimer's patients for Dartford, Gravesham and Swanley PCT.
The Department has not made an assessment of the availability of drugs for patients with moderately severe to severe Alzheimer's disease in Dartford. It is for PCTs, in conjunction with strategic health authorities to ensure that services meet local needs.